352 related articles for article (PubMed ID: 15280483)
21. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
22. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
[TBL] [Abstract][Full Text] [Related]
23. Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate.
Plotnicky H; Siegrist CA; Aubry JP; Bonnefoy JY; Corvaïa N; Nguyen TN; Power UF
Vaccine; 2003 Jun; 21(19-20):2651-60. PubMed ID: 12744902
[TBL] [Abstract][Full Text] [Related]
24. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
Castilow EM; Meyerholz DK; Varga SM
J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447
[TBL] [Abstract][Full Text] [Related]
25. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
[TBL] [Abstract][Full Text] [Related]
26. Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.
Rey GU; Miao C; Caidi H; Trivedi SU; Harcourt JL; Tripp RA; Anderson LJ; Haynes LM
PLoS One; 2013; 8(12):e83075. PubMed ID: 24376637
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.
Srinivasa BT; Fixman ED; Ward BJ
Eur J Immunol; 2014 Aug; 44(8):2349-59. PubMed ID: 24796717
[TBL] [Abstract][Full Text] [Related]
28. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
29. Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
Hwang HS; Lee YT; Kim KH; Ko EJ; Lee Y; Kwon YM; Kang SM
Virology; 2017 Nov; 511():142-151. PubMed ID: 28846899
[TBL] [Abstract][Full Text] [Related]
30. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
31. CD4
Schneider-Ohrum K; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; Cheng LI; O'Day T; Cayatte C
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092578
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.
Connors M; Kulkarni AB; Firestone CY; Holmes KL; Morse HC; Sotnikov AV; Murphy BR
J Virol; 1992 Dec; 66(12):7444-51. PubMed ID: 1433525
[TBL] [Abstract][Full Text] [Related]
33. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide Inhibits FI-RSV Vaccine-enhanced Inflammation Through Regulating Th Responses.
Yin W; Li HY; Zheng BY; Deng YQ; Li WJ; Liu Y; Zeng RH
Curr Med Sci; 2019 Jun; 39(3):363-370. PubMed ID: 31209804
[TBL] [Abstract][Full Text] [Related]
35. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.
Connors M; Giese NA; Kulkarni AB; Firestone CY; Morse HC; Murphy BR
J Virol; 1994 Aug; 68(8):5321-5. PubMed ID: 8035532
[TBL] [Abstract][Full Text] [Related]
36. Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.
De Swart RL; Kuiken T; Timmerman HH; van Amerongen G; Van Den Hoogen BG; Vos HW; Neijens HJ; Andeweg AC; Osterhaus AD
J Virol; 2002 Nov; 76(22):11561-9. PubMed ID: 12388717
[TBL] [Abstract][Full Text] [Related]
37. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
[TBL] [Abstract][Full Text] [Related]
38. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.
Castilow EM; Olson MR; Varga SM
Immunol Res; 2007; 39(1-3):225-39. PubMed ID: 17917067
[TBL] [Abstract][Full Text] [Related]
39. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.
Murawski MR; McGinnes LW; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Heaton PM; Fraire AE; Morrison TG
J Virol; 2010 Jan; 84(2):1110-23. PubMed ID: 19889768
[TBL] [Abstract][Full Text] [Related]
40. Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.
Power UF; Huss T; Michaud V; Plotnicky-Gilquin H; Bonnefoy JY; Nguyen TN
J Virol; 2001 Dec; 75(24):12421-30. PubMed ID: 11711632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
